A Clinical Trial to study the effect of the Drug Naaval nei in patients with high bleeding during menstruation

A clinical study on Pitha Perumbadu (Menorrhagia) with the evaluation of Siddha drug Naaval nei.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/05/008615

Enrollment

Registered

2017-05-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Pitha Perumbadu (Menorrhagia)

Interventions

Intervention1: Naaval Nei: 5 ml of Naaval nei is administered thrice a day for 48 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Patients with the following signs and symptoms Excessive menstruation Prolonged menstruation Presence of Blodd clots in menstrual bleeding Lower abdominal pain Low back ache Triedness during menstruation Giddiness during menstruation Head ache durring menstruation USG report with Fibroid uterus or PCOD or Ovarian cyst

Exclusion criteria

Exclusion criteria: Pelvic pathology Diabetes mellitus Hypertension Patients having IUCD Abortion Thrombocytopenic purpura Coagulopathy Severe Anemia ( Hypothyroidism Vulnerable population such as HIV and TB affected individuals

Design outcomes

Primary

Measure	Time frame
Outcome is mainly assessed by reduction in clinical symptoms and by comparing the following parameters before and after treatment. Reduced amount of blood flow is assessed by bleeding time, clotting time And HaemoglobinTimepoint: 48 days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr S Jayapriya

Govt Siddha Medical College

nanbu.sumi@gmail.com9443279412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026